Charity aims to encourage the prioritization of sight loss in NHS

Article

More attention should be paid to dealing with sight loss, claims a new report created by ocular charity Visionary.

More attention should be paid to dealing with sight loss, claims a new report created by ocular charity Visionary.

The research is based on an evaluation of 68 Primary Care Trusts (PCTs) completed by the charity. The results revealed a significant difference in the level and quality of treatment administered across the UK.

Visionary is encouraging the NHS Commissioning Board to take action to ensure eye care is equally prioritized nationwide. The NHS initiative Action on Cataract aimed to perform 3200 cataract procedures per 100000 in patients over 65 years of age. However, the latest findings show that 11 PCTs in the UK are not reaching this target.

Angela Tinker, Chief Executive of Visionary, commented, "It is frightening that in the modern health service the reality is you could lose your sight despite there being effective treatments available. People should not be made to live with the devastating effects of sight loss or impairment simply because of where they live."

"At a local level we want to make sure systems are in place in the new NHS to help people get the right treatment fast. At the national level we want to ensure that the power is in place to redress the imbalance in the current postcode lottery to avoid unnecessary sight impairment and sight loss which seems inevitable in the current conditions."

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.